Request for Information (RFI): Commercial Off-the-Shelf Task Management Tool
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
FDA-RFI-2026-131587
NAICS
-
Classification Code
-
Additional Details
Documents2
The U.S. Food and Drug Administration (FDA), through its Office of Acquisition and Grant Services, has issued a Request for Information (RFI) to assess market capabilities for providing a Commercial Off-the-Shelf (COTS) Task Management Tool. This sources sought notice, identified by procurement number FDA-RFI-2026-131587, is intended to gather input from industry vendors regarding solutions that can support the FDA’s enterprise-wide requirements for effective task management.
The primary objective of this RFI is to understand the availability and suitability of COTS task management tools that can be deployed across the FDA’s operations. The agency seeks information on products that can enhance organizational efficiency, streamline task tracking, and facilitate collaboration among its teams. The scope of the anticipated solution encompasses robust task management functionalities that are scalable and adaptable to the FDA’s diverse operational needs.
Key requirements for the proposed tool include comprehensive task tracking, assignment, and monitoring capabilities, as well as features that support collaboration, reporting, and integration with existing FDA systems. The FDA is particularly interested in solutions that are ready for immediate deployment, minimizing the need for extensive customization or development. Respondents are expected to provide details on their product’s features, technical specifications, and support services, as well as their experience in delivering similar solutions to large federal organizations.
The place of performance for this requirement is Silver Spring, Maryland, United States. The contracting entity is the FDA Office of Acquisition and Grant Services, a federal office responsible for managing procurement activities for the agency. Interested parties may direct inquiries and submit responses to the designated contacts: Lilibeth Deato ([email protected]) and Min Jie Zeng ([email protected]).
This notice is classified as a sources sought and does not constitute a formal solicitation or request for proposals. No set-aside requirements or special considerations have been specified at this stage. The FDA has issued Amendment 1 to address vendor questions and extend the response due date to November 20, 2025, at 5:00 PM EST. The notice remains active and can be accessed via the SAM.gov portal at https://sam.gov/opp/91b40c5927344314a6471fcbce21473e/view, where additional attachments may be available for review.
Contractors evaluating this opportunity should note that the FDA is seeking information to inform future procurement actions and is interested in solutions that can deliver consistent, reliable task management capabilities over the contract lifecycle. Respondents are encouraged to provide thorough and relevant information that demonstrates their product’s alignment with the FDA’s enterprise needs.